Member Info for andyrp

I’m no longer invested and I’m not deramping either ( why would I as I don’t want an entry point). I am however more than keen to make people aware what a dog of a share UKOG is and stop them being sucked in by under water shareholders desperate for an exit point.

If you genuinely believed in this share and the future of UKOG then -1.92% is no more of an opportunity to top up than the SP was yesterday. “Top up opportunity” - I have never heard such utter tosh.

Nice SP movement on no news; does somebody know something is mere mortals are not privy to?

11am on Monday.

You beat me to it, the RNS might have sparked some interest - if it's good enough for a director to increase his holdings that only sends positive messages as far as I am concerned.

Great work to develop new tests and revenue streams but that was not the RNS we were hoping for. Invested here but think this RNS could have a negative effect, I hope not and time will tell. We want contract news!!!!!!!

Started to feel a little annoyed at the lack of news I suspect; I’m the same. GM needs to get the PR machine fired up and stop thinking that mid cap means they don’t need to inform the market of changes; his approach to materiality is damaging the share price as investors start looking elsewhere. We need news! Fingers crossed there’s a big announcement (phase 2 contract) being drafted right now.

Longest opening auction ever! Come in - what’s the opening price.

RNS out, dosing started in the US. Today will be a good day.

Me too! There’s a bit of noise stirring about this one so happy to be onboard early.

Covid was the making of this company but I wonder if it’s holding it back now in terms of a re-rate as the market can’t see the true value of the company. We now have a global diagnostics business with a track record of rapidly developing new tests yet the market seems transfixed on valuing based on Covid only and not the real long term potential for NCYT. Patience is key.

Somebody replies with “topped up”! Really? In a share currently suspended from trading.

I’m on a free carry here and this still hurts! We’ve seen how quickly this can go up so just sit tight and “enjoy” the ride.

Given that a successful trial and / or emergency use approval will create significant demand for product then I am very sure that production “at risk” will have started. Production costs are negligible in comparison to the total R&D costs plus costs for getting the marketing authorisation / regulatory approval.

Some look, some see. Many of us looked at the RNS but credit to Phoebus for seeing what this really meant!!! It now feels even more positive and gives an even better outlook for the future.

Variplex?

Not just next week but by 2pm on Tuesday!

Looking good, 2021 has been a good year for my investments so far.

“fund raise coming” you know it, I know it, SS knows it, everyone knows it! Of course a fund raise is coming; SS has lights in both UK and Turkey to keep on now!

£10 here soon which will be a nice milestone ahead of all of the impending news.